OCD Treatments: Cannabis Falls Short, TMS Disrupts Compulsions
Huberman Lab unpacks alternative OCD therapies: why cannabis underperforms placebo, how TMS can interrupt compulsive behaviors, and the nuanced role of mindfulness.
40 hours of podcasts, in 5 minutes.
Andrew Huberman discusses the intricate nature of Obsessive-Compulsive Disorder (OCD), detailing its symptoms, prevalence, and underlying neural circuitry. He explores various treatment modalities, including the highly effective cognitive behavioral therapy (CBT) and exposure and ritual prevention (ERP), comparing their efficacy with that of SSRIs and other alternative therapies. The episode provides insights into diagnosis, the mechanisms of OCD, and actionable information for those seeking or applying treatments.
Huberman Lab unpacks alternative OCD therapies: why cannabis underperforms placebo, how TMS can interrupt compulsive behaviors, and the nuanced role of mindfulness.
Huberman Lab reveals cognitive behavioral therapy dramatically outperforms SSRIs for OCD, even when combined, challenging common treatment assumptions.
Huberman reveals the corticostriothalamic loop underlying OCD. Learn how this brain circuit can illuminate stubborn patterns in your startup, and how to break them.
Andrew Huberman reveals the Y-BOCS, a diagnostic tool for OCD. Learn how precisely identifying your biggest, most catastrophic fears can break self-defeating loops.
Andrew Huberman reveals how behaviors designed to relieve anxiety actually strengthen it. Founders: identify your work 'compulsions' and break the cycle.